Skip to main content
Top
Published in: Journal of Inflammation 1/2011

Open Access 01-12-2011 | Research

Activation of monocytes and cytokine production in patients with peripheral atherosclerosis obliterans

Authors: Camila R Corrêa, Luciane A Dias-Melicio, Sueli A Calvi, Sidney Lastória, Angela MVC Soares

Published in: Journal of Inflammation | Issue 1/2011

Login to get access

Abstract

Background

Arterial peripheral disease is a condition caused by the blocked blood flow resulting from arterial cholesterol deposits within the arms, legs and aorta. Studies have shown that macrophages in atherosclerotic plaque are highly activated, which makes these cells important antigen-presenting cells that develop a specific immune response, in which LDLox is the inducing antigen. As functional changes of cells which participate in the atherogenesis process may occur in the peripheral blood, the objectives of the present study were to evaluate plasma levels of anti-inflammatory and inflammatory cytokines including TNF-α, IFN-γ, interleukin-6 (IL-6), IL-10 and TGF-β in patients with peripheral arteriosclerosis obliterans, to assess the monocyte activation level in peripheral blood through the ability of these cells to release hydrogen peroxide (H2O2) and to develop fungicidal activity against Candida albicans (C. albicans) in vitro.

Methods

TNF-α, IFN-γ, IL-6, IL-10 and TGF-β from plasma of patients were detected by ELISA. Monocyte cultures activated in vitro with TNF-alpha and IFN-gamma were evaluated by fungicidal activity against C. albicans by culture plating and Colony Forming Unit (CFU) recovery, and by H2O2 production.

Results

Plasma levels of all cytokines were significantly higher in patients compared to those detected in control subjects. Control group monocytes did not release substantial levels of H2O2in vitro, but these levels were significantly increased after activation with IFN-γ and TNF-α. Monocytes of patients, before and after activation, responded less than those of control subjects. Similar results were found when fungicidal activity was evaluated. The results seen in patients were always significantly smaller than among control subjects. Conclusions: The results revealed an unresponsiveness of patient monocytes in vitro probably due to the high activation process occurring in vivo as corroborated by high plasma cytokine levels.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gornik HL, Beckman JA: Peripheral arterial disease. Circulation. 2005, 111: e169-e172. 10.1161/01.CIR.0000160581.58633.8B.PubMedCrossRef Gornik HL, Beckman JA: Peripheral arterial disease. Circulation. 2005, 111: e169-e172. 10.1161/01.CIR.0000160581.58633.8B.PubMedCrossRef
2.
go back to reference Fuhrman B, Partoush A, Volkova N: Ox-LDL induces monocyte-to-macrophage differentiation in vivo: Possible role for the macrophage colony stimulanting factor receptor (M-CSF-R). Atherosclerosis. 2008, 196: 598-607. 10.1016/j.atherosclerosis.2007.06.026.PubMedCrossRef Fuhrman B, Partoush A, Volkova N: Ox-LDL induces monocyte-to-macrophage differentiation in vivo: Possible role for the macrophage colony stimulanting factor receptor (M-CSF-R). Atherosclerosis. 2008, 196: 598-607. 10.1016/j.atherosclerosis.2007.06.026.PubMedCrossRef
3.
go back to reference Levitan I, Volkov S, Subbaiah PV: Oxidized LDL: Diversity, patters of recognition, and pathophisiology. Antioxid Redox Signal. 2010, 13: 39-75. 10.1089/ars.2009.2733.PubMedPubMedCentralCrossRef Levitan I, Volkov S, Subbaiah PV: Oxidized LDL: Diversity, patters of recognition, and pathophisiology. Antioxid Redox Signal. 2010, 13: 39-75. 10.1089/ars.2009.2733.PubMedPubMedCentralCrossRef
4.
go back to reference Zimmerman MA, Reznikov LL, Raeburn CD: Interleukin-10 attenuates the response to vascular injury. J Surg Res. 2004, 121: 206-213. 10.1016/j.jss.2004.03.025.PubMedCrossRef Zimmerman MA, Reznikov LL, Raeburn CD: Interleukin-10 attenuates the response to vascular injury. J Surg Res. 2004, 121: 206-213. 10.1016/j.jss.2004.03.025.PubMedCrossRef
5.
go back to reference Stemme S, Faber B, Holm J: T Lymphocytes from human atherosclerosis plaques recognize oxidized low-density lipoprotein. Proc Natl Acad Sci USA. 1995, 92: 3893-3897. 10.1073/pnas.92.9.3893.PubMedPubMedCentralCrossRef Stemme S, Faber B, Holm J: T Lymphocytes from human atherosclerosis plaques recognize oxidized low-density lipoprotein. Proc Natl Acad Sci USA. 1995, 92: 3893-3897. 10.1073/pnas.92.9.3893.PubMedPubMedCentralCrossRef
6.
go back to reference Angerio AD: Interferon and health disease. Crit Care Nurs. 2009, 32: 159-162.CrossRef Angerio AD: Interferon and health disease. Crit Care Nurs. 2009, 32: 159-162.CrossRef
7.
go back to reference Ikeda U, Ikeda M, Seino Y: Interleukin-6 gene transcripts are expressed in atherosclerotic lesions of genetically hiperlipidemic rabbits. Atherosclerosis. 1992, 92: 213-213. 10.1016/0021-9150(92)90280-T.PubMedCrossRef Ikeda U, Ikeda M, Seino Y: Interleukin-6 gene transcripts are expressed in atherosclerotic lesions of genetically hiperlipidemic rabbits. Atherosclerosis. 1992, 92: 213-213. 10.1016/0021-9150(92)90280-T.PubMedCrossRef
8.
go back to reference Varadhachary AS, Monestier M, Salgame P: Reciprocal induction of IL-10 and IL-12 from macrophages by low-density lipoprotein and its oxidized forms. Cellular Immunology. 2001, 213: 45-45. 10.1006/cimm.2001.1855.PubMedCrossRef Varadhachary AS, Monestier M, Salgame P: Reciprocal induction of IL-10 and IL-12 from macrophages by low-density lipoprotein and its oxidized forms. Cellular Immunology. 2001, 213: 45-45. 10.1006/cimm.2001.1855.PubMedCrossRef
9.
go back to reference Pick E, Keisari Y: A simple colorimetric method for the measurement of hydrogen peroxidase by cells in culture. J Immunol Methods. 1980, 36: 161-161.CrossRef Pick E, Keisari Y: A simple colorimetric method for the measurement of hydrogen peroxidase by cells in culture. J Immunol Methods. 1980, 36: 161-161.CrossRef
10.
go back to reference Pick E, Mizel D: Rapid microassay for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using in automatic enzyme immunoassay reader. J Immunol Methods. 1981, 46: 211-226. 10.1016/0022-1759(81)90138-1.PubMedCrossRef Pick E, Mizel D: Rapid microassay for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using in automatic enzyme immunoassay reader. J Immunol Methods. 1981, 46: 211-226. 10.1016/0022-1759(81)90138-1.PubMedCrossRef
11.
go back to reference Zar JH: Bioestatistical analysis. 1998, Englandood cliffs. Prentice hall Zar JH: Bioestatistical analysis. 1998, Englandood cliffs. Prentice hall
12.
go back to reference Ridker PM, Hennekens CH, Buring JE: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. The New England Journal of Medicine. 2000, 342: 836-843. 10.1056/NEJM200003233421202.PubMedCrossRef Ridker PM, Hennekens CH, Buring JE: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. The New England Journal of Medicine. 2000, 342: 836-843. 10.1056/NEJM200003233421202.PubMedCrossRef
13.
go back to reference Ridker PM, Stampfer MJ, Rifai N: Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein (a), and standart cholesterol screening as predictors of peripheral arterial disease. J Am Med Assoc. 2001, 285: 2481-2585. 10.1001/jama.285.19.2481.CrossRef Ridker PM, Stampfer MJ, Rifai N: Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein (a), and standart cholesterol screening as predictors of peripheral arterial disease. J Am Med Assoc. 2001, 285: 2481-2585. 10.1001/jama.285.19.2481.CrossRef
14.
go back to reference Genest J: Lipoprotein disorders and cardiovascular risk. J Inherit Metab Dis. 2003, 26: 267-287. 10.1023/A:1024449603891.PubMedCrossRef Genest J: Lipoprotein disorders and cardiovascular risk. J Inherit Metab Dis. 2003, 26: 267-287. 10.1023/A:1024449603891.PubMedCrossRef
15.
go back to reference Hochepied T, Berger FG, Baumann H: Alpha-1- acid glicoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth factor Rev. 2003, 14: 25-32. 10.1016/S1359-6101(02)00054-0.PubMedCrossRef Hochepied T, Berger FG, Baumann H: Alpha-1- acid glicoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth factor Rev. 2003, 14: 25-32. 10.1016/S1359-6101(02)00054-0.PubMedCrossRef
16.
go back to reference Robbesyn F, Garcia V, Auge N: HDL counterbalances the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF-kB activation in smooth muscle cells. The FASEB Journal. 2003, 17: 743-745.PubMed Robbesyn F, Garcia V, Auge N: HDL counterbalances the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF-kB activation in smooth muscle cells. The FASEB Journal. 2003, 17: 743-745.PubMed
17.
go back to reference Ares MPS: Atherosclerosis: cell biology and lipoproteins. Current Opinion Lipidology. 2004, 15: 231-234. 10.1097/00041433-200404000-00019.CrossRef Ares MPS: Atherosclerosis: cell biology and lipoproteins. Current Opinion Lipidology. 2004, 15: 231-234. 10.1097/00041433-200404000-00019.CrossRef
18.
go back to reference Corrado E, Rizzo M, Coppola G: An update on the role of markers of inflammation in atherosclerosis. J Atherosclerosis and Thrombosis. 2010, 17: 1-11. 10.5551/jat.2600.CrossRef Corrado E, Rizzo M, Coppola G: An update on the role of markers of inflammation in atherosclerosis. J Atherosclerosis and Thrombosis. 2010, 17: 1-11. 10.5551/jat.2600.CrossRef
19.
go back to reference De Palma RG, Hayes VW, Cafferata HT: Cytokine signatures in atherosclerotic claudicants. J Surg Res. 2003, 111: 215-221. 10.1016/S0022-4804(03)00075-1.CrossRef De Palma RG, Hayes VW, Cafferata HT: Cytokine signatures in atherosclerotic claudicants. J Surg Res. 2003, 111: 215-221. 10.1016/S0022-4804(03)00075-1.CrossRef
20.
go back to reference Tentolouris C, Tousoulis D, Antoniades C: Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy. Int J cardiol. 2004, 94: 301-305. 10.1016/j.ijcard.2003.08.002.PubMedCrossRef Tentolouris C, Tousoulis D, Antoniades C: Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy. Int J cardiol. 2004, 94: 301-305. 10.1016/j.ijcard.2003.08.002.PubMedCrossRef
21.
go back to reference Fiotti N, Giansante C, Ponte E: Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral artherial disease. Atherosclerosis. 1999, 145: 51-60. 10.1016/S0021-9150(99)00013-1.PubMedCrossRef Fiotti N, Giansante C, Ponte E: Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral artherial disease. Atherosclerosis. 1999, 145: 51-60. 10.1016/S0021-9150(99)00013-1.PubMedCrossRef
22.
go back to reference Fernades JL, Manomi RL, Orford JL: Increased Th1 activity in patients with coronary artery disease. Cytokine. 2004, 26: 131-137. 10.1016/j.cyto.2004.01.007.CrossRef Fernades JL, Manomi RL, Orford JL: Increased Th1 activity in patients with coronary artery disease. Cytokine. 2004, 26: 131-137. 10.1016/j.cyto.2004.01.007.CrossRef
23.
go back to reference Zimmerman MA, Reznikov LL, Raeburn CD: Interleukin-10 attenuates the response to vascular injury. J Surg Res. 2004, 121: 206-213. 10.1016/j.jss.2004.03.025.PubMedCrossRef Zimmerman MA, Reznikov LL, Raeburn CD: Interleukin-10 attenuates the response to vascular injury. J Surg Res. 2004, 121: 206-213. 10.1016/j.jss.2004.03.025.PubMedCrossRef
24.
go back to reference Ikonomidis I, Stamatelopoulos K, Lekakis J: Inflammatory and non-invasive vascular markers: The multimarker approach for risk stratification in coronary artery disease. Atherosclerosis. 2008, 199: 3-11. 10.1016/j.atherosclerosis.2008.02.019.PubMedCrossRef Ikonomidis I, Stamatelopoulos K, Lekakis J: Inflammatory and non-invasive vascular markers: The multimarker approach for risk stratification in coronary artery disease. Atherosclerosis. 2008, 199: 3-11. 10.1016/j.atherosclerosis.2008.02.019.PubMedCrossRef
25.
go back to reference Molavi B, Mehta JL: Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations. Current Opinion in Cardiology. 2004, 19: 488-493. 10.1097/01.hco.0000133657.77024.bd.PubMedCrossRef Molavi B, Mehta JL: Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations. Current Opinion in Cardiology. 2004, 19: 488-493. 10.1097/01.hco.0000133657.77024.bd.PubMedCrossRef
26.
go back to reference Eligini S, Colli S, Basso F: Oxidized low density lipoprotein suppresses expression of inducible cycloxigenase in macrophage. Arterioscler Thromb Vasc Biol. 1999, 19: 1719-1725. 10.1161/01.ATV.19.7.1719.PubMedCrossRef Eligini S, Colli S, Basso F: Oxidized low density lipoprotein suppresses expression of inducible cycloxigenase in macrophage. Arterioscler Thromb Vasc Biol. 1999, 19: 1719-1725. 10.1161/01.ATV.19.7.1719.PubMedCrossRef
27.
go back to reference Leventhal AR, Leslie CC, Tabas I: Supression of macrophage eicosanoid synthesis by atherogenic lipoproteins is profoundly affected by cholesterol-fatty acyl esterification and the niemann-pick c pathway of lipid trafficking. The Journal of Biological Chemistry. 2004, 279: 8084-8092.PubMedCrossRef Leventhal AR, Leslie CC, Tabas I: Supression of macrophage eicosanoid synthesis by atherogenic lipoproteins is profoundly affected by cholesterol-fatty acyl esterification and the niemann-pick c pathway of lipid trafficking. The Journal of Biological Chemistry. 2004, 279: 8084-8092.PubMedCrossRef
Metadata
Title
Activation of monocytes and cytokine production in patients with peripheral atherosclerosis obliterans
Authors
Camila R Corrêa
Luciane A Dias-Melicio
Sueli A Calvi
Sidney Lastória
Angela MVC Soares
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Inflammation / Issue 1/2011
Electronic ISSN: 1476-9255
DOI
https://doi.org/10.1186/1476-9255-8-23

Other articles of this Issue 1/2011

Journal of Inflammation 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.